According to IMARC Group, the global molecular cytogenetics market is expected to continue its strong growth during the next five years. To learn more about this market, visit us at: https://www.imarcgroup.com/molecular-cytogenetics-market We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. The report provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players. For more information, request for a free sample report here: https://www.imarcgroup.com/molecular-cytogenetics-market/requestsample Contact Us: IMARC Group 30 N Gould St, Ste R Sheridan, WY (Wyoming) 82801 USA Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

1. www.imarcgroup.com Sales@imarcgroup.com +1-631-791-1145
Global Molecular Cytogenetics Market Research Report and Forecast 2020 - 2025

2. About IMARC
WHO WE ARE?
• We are a leading market
research firm with
expertise in market
intelligence and business
research
• We deliver high quality,
well-knitted, meaningful
studies
• We excel at understanding
and synergizing with the
business priorities of our
partners and delivering
tailored solutions
WHAT DO WE DO?
• Market research and
business insights
• Competitive intelligence
and benchmarking
• Strategy consulting
• Consumer surveys and
feedback analysis
• Social and rural research
• Market entry strategy
• Syndicated Reports
WHAT DO WE COVER?
• Food And beverages
• Dairy and dairy products
• Agriculture and farming
• Chemicals and materials
• FMCG
• Paper and packaging
• Healthcare
• Machinery, electronics and
semiconductors
WHO DO WE SERVE?
• Collaborating with fortune
500 companies and SMEs
• Serving all major clients
from different industry
which include Chemical &
Materials, Food &
Beverages, Packaging,
Healthcare, Automotive,
Heavy Industries, Retail,
etc.

3. WhatWeDo
Cost Modeling and Cost Forecasting
Competitive Intelligence and Benchmarking
Country Entry Strategy
Consumer Survey & Feedback Reports
A good cost model supports organizations during negotiations to build strong
relationships with suppliers. Cost modelling and price forecasting services from
IMARC ensure clients make informed decisions.
At IMARC, we help customers determine a competitor’s brand image and
perception in the marketplace as compared to other key players.
IMARC team drafts and implement an optimum country entry strategy for
expanding business in the country. Our team of consultants deeply evaluates
and strategize the market opportunities for our clients and accentuate the
business in congruence with Government regulations, exports and imports
scenario, demand supply gap analysis and many more.
Consumer profiling, survey with end consumers, collection of their feedback
and deep analysis. Based on the analysis, strategic decisions to enter in a
new region, launch of new product, improvising the existing services
Market Research & Business Insights
To develop deep customer understanding, we employ a range of quantitative
and qualitative marketing research approaches along with big data
techniques that are both innovative and pragmatic
Competitive
Intelligence and
Benchmarking
Cost Modeling
and Cost
Forecasting
Country Entry
Strategy
Consumer
Survey &
Feedback
Reports
Market Research
& Business
Insights

4. REPORT OBJECTIVES &
Highlight

5. According to the IMARC Group, Molecular cytogenetics includes the biomedical research of DNA mechanisms to investigate genetic
mutations and disorders. It analyzes the structural and functional organization of the chromosomes and their nucleus, genomic variations,
expression, evolution and abnormalities, particularly in medicinal and cancer-related genetics. Several techniques, such as DNA isolation,
DNA amplification, gene screens, virtual karyotyping and fluorescence in-situ hybridization (FISH), are commonly used for molecular
cytogenetics. These techniques are highly beneficial in diagnosing and treating various malignant tumors and hematological malignancies.
Request for a free sample copy of this report: https://www.imarcgroup.com/molecular-cytogenetics-market/requestsample
Market Trends:
The growing prevalence of cancer and other genetic disorders is primarily driving the market growth. Furthermore, the widespread
adoption of targeted therapies, such as FISH and Comparative Genomic Hybridization (CGH), that help in analyzing cancer progression
stages and provide personalized treatment to the patient is further propelling the market. Additionally, several technological
advancements have led to the development of improved consumables, reagents, kits, etc., that aid in generating accurate and reliable
clinical-pathological test results, thereby driving the global market.
Report Description

6. Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along
with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on
region, product type, technology, application and end user.
• Breakup by Product Type:
• Instruments
• Consumables
• Software and Services
• Others
• Breakup by Technology:
• Comparative Genomic Hybridization
• Fluorescence in SITU Hybridization (FISH)
• Immunohistochemistry
• Karyotyping
• Others
• Breakup by Application:
• Genetic Disorders
• Oncology
• Personalized Medicine
• Others
Report Description

7. • Breakup by End User:
• Clinical and Research Laboratories
• Hospitals and Pathology Laboratories
• Pharmaceutical and Biotechnology Companies
• Others
• Breakup by Region:
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
Report Description

8. • Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories,
Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher
Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics
Incorporated.
Report Description

9. Explore Report Description: https://www.imarcgroup.com/molecular-cytogenetics-market
Browse Related Report By IMARC Group
Data Quality Tools Market: https://www.imarcgroup.com/data-quality-tools-market
Big Data Software Market: https://www.imarcgroup.com/big-data-software-market
3D Printing Market: https://www.imarcgroup.com/3d-printing-market
Cloud Security Software Market: https://www.imarcgroup.com/cloud-security-software-market
Report Description

10. Key Questions Answered in This Report:
•How has the global molecular cytogenetics market performed so far and how will it perform in the coming years?
•What has been the impact of COVID-19 on the global molecular cytogenetics market?
•What are the key regional markets?
•What is the breakup of the market based on the product type?
•What is the breakup of the market based on the technology?
•What is the breakup of the market based on the application?
•What is the breakup of the market based on the end user?
•What are the various stages in the value chain of the industry?
•What are the key driving factors and challenges in the industry?
•What is the structure of the global molecular cytogenetics market and who are the key players?
•What is the degree of competition in the industry?
Report Description

11. Table of Contents

12. 1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Molecular Cytogenetics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Consumables
6.2.1 Market Trends
Table of Contents

13. 6.2.2 Market Forecast
6.3 Software and Services
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Technology
7.1 Comparative Genomic Hybridization
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Fluorescence in SITU Hybridization (FISH)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Immunohistochemistry
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Karyotyping
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Application
8.1 Genetic Disorders
Table of Contents

14. 8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oncology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Personalized Medicine
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Clinical and Research Laboratories
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and Pathology Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
Table of Contents

15. 10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Othrs
Table of Contents

16. 10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
Table of Contents

17. 10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
Table of Contents

18. 14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Agilent Technologies Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Applied Spectral Imaging Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Biological Industries
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Bio-RAD Laboratories Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
Table of Contents

19. 15.3.6 BioView Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Danaher Corporation
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 F. Hoffmann-La Roche AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 SWOT Analysis
15.3.9 Illumina Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Oxford Gene Technology
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.11 Perkinelmer Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
Table of Contents

20. 15.3.12 Quest Diagnostics Incorporated
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
Table of Contents

21. Report FAQs
Team ProfileTeam Profile

22. Team Profile
Engineers
45%
Post
Graduates
30%
Non
Engineering
Graduates
15%
Others
10%
Growing team of 150+ employees with
deep market knowledge
Over 1000 Independent Consultants from
different sectors
Talents from some of the top universities
modelling specialists with unmatched
expertise in quantitative research
Individuals with experience in specific
industries and having sound knowledge of
targeted functional areas
Commercial and non-commercial
relationships with some of the top research
institutes
Engineers and Post Graduates Account for
75% of our Team

23. Report FAQs
Words From Client

24. “We have been working with IMARC Group for over two years now. I must say that the word impossible
doesn’t seems to appear in their dictionary,. These guys can provide data for any market in any country. I
have been given them challenging assignments to work upon and have been quite impressed with their
approach and results.” -Global
Procurement Technology Manager – Global FMCG Giant
“IMARC Group has great domain expertise and knowledge base provided all the inputs necessary for us to
define the path forward and launch our diagnostic successfully in the market where other players were always
afraid before investing.”
-Vice President Marketing – European Diagnostic Company
“We were really impressed with their research findings on the South India dairy market. The innovative idea
suggested by them have given us altogether different aspect to look at the problem. We started with them on
small project but now thinking on doing more strategic project with them.”
-National Manager (Marketing) – Indian Diary Giant
“IMARC Group helped us with the outsourcing of a major part of clinical trials to India. In the beginning we
were skeptic of this idea. But the success achieved from this strategy is driving us to outsource other verticals
of our business to low cost destinations”
- Member of Board of Managing Director – Global Pharmaceutical Giant
“Working with IMARC Group has been a great experience. They were able to provide us with a comprehensive
business report on the India wastewater treatment market. The finding from the reports are played a major
role in our business strategies and future decision making”
-Senior Vice President – Major Indian Effluent Treatment Company
Words From Client

25. Report FAQs
Report FAQs

26. Report FAQs
01
04
Do you provide market share information for a specific
country/segment?
Yes, we provide market share information and insights considering the scope. This service is
provided as a part of customization requirements.
I have a pre-defined budget. Can I buy chapters/sections of the report?
We generally do not promote the sale of separate or individual segments from within a study, as it
might fail to relay the actual meaning of the study or provide a holistic picture of the market. However,
in special cases, select chapters are provided based on the client requirement.
02
My research requirement is very specific; can I customized the report?
Yes, we provide customization of reports based on your requirements. It will be charged based on the scope
of customization. Client have free access to pre-sales analyst briefs to discuss requirement and
recommendations.
03
How do you arrive at the market numbers?
Our research methodology is a three cyclic process. It starts from information procurement from our
inhouse database, primary research and secondary sources. The second step is data collection and
analysis. The third step is data validation from industry experts, key players and other stakeholders.
05
Do you offer post sales support?
Yes, we offer post purchase analyst support for 4-6 weeks to our client in case they have any query within
the scope of study.

27. Report FAQs
08
06 Who are your client?
We have engaged 550+ clients across the globe. More than half of our client are re-engage us for
additional reports and services
07 How will I receive the report?
The report in a PDF and Excel format will be sent to you electronically at your registered email address.
Moreover, PPT and Word formats are also delivered to clients, on special requests.
09
How often does IMARC update studies?
Research studies or reports are updated once in 6 months or a year depending on the traction & need. Please
contact our sales team to inquire about a report update status.
Will I have to pay for the post-sale customization needs?
We offer our clients with a free 10% customization on the syndicated report. In case you have not availed this
service as a pre-sale facility, we request you to share the requirements with our sales team. The research team
post a feasibility will share the purview of the post-sale customization along with the price (if applicable) and
the timeline.

28. SOME OF OUR KEY CUSTOMERS